Dr. Larry Stowe believes that the body has an innate ability to heal itself. He says “most chronic disease can be successfully reversed by triggering the appropriate immune response. This includes arthritis, heart disease, cancer, diabetes, and fibromyalgia.”

It is certainly the case that Dr. Stowe’s childhood cancer would be classified as a spontaneous remission triggered by his immune system. His investigation of immune therapy as a treatment option for chronic disease has provided a strong insight into the concept of preventative medicine. He has always maintained that “a healthy body does not have to become diseased.”

Dr. Stowe lectures throughout the United States and internationally on the application of immune therapy, both as a preventative measure and for it’s therapeutic benefits.

The potential of immune therapy was recently demonstrated in helping Dr. Stowe's 81 year old mother achieve a remission of pancreatic cancer. Edith Stowe is nearly cancer free after 11 months of immune therapy and has lived well beyond the 2 month life expectancy given her in December of 1999.

“Biomune OSF™ played a major role in her treatment program,” acknowledged Stowe, “It’s the mainstay of her ongoing recovery. While it’s still too early to refer to her as cured, she is clearly on her way to a long and productive life extension. Her quality of life has been extraordinarily high and she is recovering from hip replacement surgery at the same time.”

“The immune therapy was used as an adjunctive therapy to the Mayo clinic radiation protocol and is a testament to integrative medicine.”

The technology behind Dr. Stowe’s company, Applied Biological Medicine, is centered on gene activation therapy, biological response modifiers, bio-terrain modification, bioresonance and hypothermia. Many of the therapies are approved by regulatory authorities outside of the United States, including Germany, Japan and Canada. Variations of these methods are under intense investigation by medical research centers throughout the United States. Each of these modalities can be thoroughly investigated on the Internet.

“Applied Biological Medicine’s cutting edge technology is all delivered within the holistic framework of the mind, body, spirit connection,” says Dr. Stowe. His current project is to work with the MindBody Health Center in the Dallas/Ft. Worth area to create a center of excellence in the application of immune therapy.

To promote the acceptance of immune therapy into mainstream medicine, Dr. Stowe has assisted in the design of several controlled clinical trials that feature immune therapy and meet the formal guidelines of the FDA. Dr. Gary Blick, a prominent clinical physician in infectious disease and an associate of Dr. Stowe, is currently the chief investigator for a phase II FDA clinical trial on whole body hypothermia (WBH) and its application to viral infections.

WBH is an immune therapy protocol he pioneered in cooperation with the Ministry of Health in Mexico for the treatment of cancer. WBH is now an approved therapy in Mexico and being developed in the United States and Europe by First Circle Medical, Inc.

Cancer vaccines, a form of gene activation therapy utilized in immune therapy, are under development by Avax Technologies, Inc. and Cell Genesys, Inc. in the United States. The US vaccines are in clinical trials and not available to the public at large, but Dr. Stowe says, “Applied Biological Medicine can supply the European equivalent through its relationship with the Institute of Cell Biology and Immunology in Munich Germany.”

Dr. Stowe is also a small business technology partner with Los Alamos National Laboratory specializing in the application of resonant frequencies to commercial processes. “Biological tissue responds in very interesting ways when stimulated with the appropriate frequency,” professes Dr. Stowe, “Immune therapy is not the application of one single therapy, but rather the combination that best serves the patient.”

He obtained his Ph.D. in Chemical Engineering from the University of Illinois in 1982 and his masters degrees in both Chemical Engineering and Biomedical Engineering from Iowa State University in 1978. His graduate work focused on the application of engineering principles to human physiology. He completed his bachelor's degree in Chemical Engineering at Iowa State in 1975.

Dr. Stowe believes, “engineering teaches the student to focus on a system analysis. The human system is a complex mixture of interactions between the energy pathways, biochemical reactions, electrical circuits, magnetic fields, cell communication, thought patterns, and spiritual guidance. This offers a significantly different perspective to the treatment and cause of disease.”

Early in his career, Dr. Stowe was a senior research engineer for Mobil Oil Research and Development. During that time he was granted 16 US patents and 2 foreign patents for inventions related to the oil industry. The technology that developed from those patents had a significant affect on Mobil's bottom line.

Bridging the gap between research and development and the commercial application of technology, Dr. Stowe became a technical consultant to Mobil Oil Exploration and Production. His primary responsibility was to implement new production technology for Mobil's worldwide operations. Dr. Stowe left the oil industry in 1989 to pursue his long standing interest in medical research.

“The rather simple biochemical model, which dominates the medical philosophy of the US, contains what Mobil Research would refer to as a fatal flaw.” He went on to say that, “if the model is not appropriate to the system, you cannot expect trustworthy results in the research and development of new technology. Chemotherapy fits the definition of a technology having a fatal flaw. The study of immune therapy attempts to correct the path of western allopathic medicine. The presence of chronic disease in epidemic proportions is the proof that the correction is needed.”

His goal is to make immune therapy a standard treatment option available to the US public. He says, “Matol is making that goal a reality. The Matol product line includes products required to strengthen the immune system.”

Dr. Stowe uses four of the Matol products with every cancer patient that comes to his treatment center. He believes that “there are two superstar Matol products that cannot be matched, Matol®/Km® and Biomune OSF™. They are both very powerful Biological Response Modifiers. These two products can activate an immune response even when the patient is in a terminal condition. Matol®/Km® operates on the cell mediated side of the immune system and Biomune OSF™ on the antigen independent Natural Killer Cells.”

Dr. Stowe is also impressed with Matol’s Omega 3-6-9 (EFA) which “provides the right essential fatty acids needed to generate the prostaglandins that regulate immune cell function” and the BotanEllE™ Progesterone Cream “which helps eliminate the estrogen dominance that plagues most cancer patients.”

Dr. Stowe will be adding Matol’s new antioxidant, OPCs + II to the lineup to fight free radicals and says, “Cancer patients who do not come with a supplement program are advised to add Matolife™ and FibreSonic® to their nutritional program.

When you consider the entire program, it is apparent that the Health Pack coupled with Progesterone Creme, might just be the most exciting package on the market. Especially if this program is combined with a strong detoxification protocol, such as chelation therapy.”

These are the concepts that Dr. Stowe teaches at the Matol product training seminars which are the equivalent to his lectures at medical conventions.

Dr. Stowe points out that Joseph Angele is a classic example of the power of the Matol lineup. “Joseph started on the Km®, Biomune OSF™, Omega 3-6-9 and Progesterone creme when he was being assigned to hospice care for terminal lung cancer. His prognosis was three to four months to live as documented by his medical team. It was anticipated that he would be bedridden and on extensive pain killers within weeks.”

“Joseph proved the experts wrong,” Dr. Stowe says proudly, “he is fully functional and is progressing nicely as a patient at my clinic as well as at home under the care of his wife Bonnie and daughter Adele. When home he actually goes to work three days per week. His death sentence has been put on hold.”

When aksed if everyone could achieve similar spectacular results, Dr. Stowe concedes “perhaps not, but there is a chance being on the products. That’s my message. Give yourself and your family a chance. Take the Matol products... I do.”